m6A-centered Drug Response Information

General Information of the Drug (ID: M6APDG00722)
Name
(11H-Dibenzo[b,e][1,4]dioxepin-7-yl)-acetic acid
Synonyms
CHEMBL32961; ZINC29223888
    Click to Show/Hide
Status
Investigative
Structure
Formula
C15H12O4
InChI
1S/C15H12O4/c16-15(17)8-10-5-6-13-14(7-10)19-12-4-2-1-3-11(12)9-18-13/h1-7H,8-9H2,(H,16,17)
InChIKey
MREFHNNUMIAIHP-UHFFFAOYSA-N
PubChem CID
13640143
TTD Drug ID
D0X5RR
Target Gene(s) and Their Upstream m6A Regulator, Together with the Effect of Target Gene(s) in Drug Response
The target genes involved in drug-target interaction (such as drug-metabolizing enzymes, drug transporters and therapeutic targets) and drug-mediated cell death signaling (including modulating DNA damage and repair capacity, escaping from drug-induced apoptosis, autophagy, cellular metabolic reprogramming, oncogenic bypass signaling, cell microenvironment, cell stemness, etc.) could be regulated by m6A regulator(s) and affected their corresponding drug response. You can browse detailed information on drug-related target gene(s) mediated by m6A regulators.
Prostaglandin G/H synthase 2 (COX-2)
Methyltransferase-like 3 (METTL3)
In total 1 mechanisms lead to this potential drug response
 Regulator Info 
Response Summary Prostaglandin G/H synthase 2 (COX-2) is a therapeutic target for (11H-Dibenzo[b,e][1,4]dioxepin-7-yl)-acetic acid. The Methyltransferase-like 3 (METTL3) has potential in affecting the response of (11H-Dibenzo[b,e][1,4]dioxepin-7-yl)-acetic acid through regulating the expression of Prostaglandin G/H synthase 2 (COX-2). [1], [2]
References
Ref 1 METTL3 promotes experimental osteoarthritis development by regulating inflammatory response and apoptosis in chondrocyte. Biochem Biophys Res Commun. 2019 Aug 13;516(1):22-27. doi: 10.1016/j.bbrc.2019.05.168. Epub 2019 Jun 8.
Ref 2 Design and synthesis of 1,3-diarylurea derivatives as selective cyclooxygenase (COX-2) inhibitors. Bioorg Med Chem Lett. 2008 Feb 15;18(4):1336-9. doi: 10.1016/j.bmcl.2008.01.021. Epub 2008 Jan 11.